TCTR20191106001招募中未知
Population Pharmacokinetics of Meropenem in Critically Ill Infant Patients
The 90th Anniversary of Chulalongkorn University Fund0 个研究点目标入组 40 人开始时间: 2019年11月6日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
- 入组人数
- 40
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 1 Months 至 2 Years（—）
- 性别
- All
入选标准
- •1. Patients were aged 1 month - 2 years
- •2. Patients admitted to pediatrics intensive care unit (PICU) or patients admitted to outside the PICU that they were criteria as follows
- •- Patients had been diagnosed with sepsis
- •- Patients had been diagnosed with septic shock
- •- Patients had quick SOFA scores ≥ 2 while receiving the meropenem
- •- Patients were receiving vasopressor drug while receiving the meropenem
- •- Patients used invasive mechanical ventilation while receiving the meropenem
- •3. Patients were receiving meropenem therapy
排除标准
- •1. Patients had meropenem allergy or history meropenem allergy
- •2. Patients had weight lower 3 kilograms
- •3. Patients had preterm birth history
- •4. Patients had creatinine clearance < 50 ml/min/1.73 m2
- •5. Patients were receiving renal replacement therapy or kidney transplant
- •6. Patients were receiving drug interaction with meropenem that valproic acid and probenecid
- •7. Parent of infant patients did not consent to attend research or patients did not have childcare obviously
研究者
相似试验
已完成
不适用
Pharmacokinetics(PK) study of meropenem in Epithelial Lining Fluid (ELF), an open-label studyHealthy volunteerJPRN-UMIN000010941Keio University, School of Medicine9
进行中（未招募）
1 期
Kinetic of Meropenem administration on 12 hours dailyEUCTR2019-003900-10-BECliniques universitaires Saint-Luc20
进行中（未招募）
不适用
Meropenem fot the treatment of serious bacterial infections in neonates and young infantssuspected or proven late onset neonatal sepsisMedDRA version: 14.1Level: PTClassification code 10040049Term: Sepsis neonatalSystem Organ Class: 10021881 - Infections and infestationsEUCTR2011-001515-31-LTPENTA Foundation Onlus550
招募中
2 期
The effect of continuous infusion ?of Meropenem antibiotic ?? in Clinical ?symptoms and Procalcitonin changes in sever sepsisAcute sepsis.Streptococcal sepsis, unspecifiedIRCT20141209020258N65Arak University of Medical Sciences60
已完成
2 期
Pharmacokinetics and safety of Meropenem in infants below 90 days of age (inclusive) with probable and confirmed meningitis: a European multicenter phase I- II trialbacterial meningitisinfection of the central nervous system1000401810007951NL-OMON39472PENTA Foundation / Dept. of Pediatrics10